Status:
ACTIVE_NOT_RECRUITING
Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study
Lead Sponsor:
Imperial College London
Conditions:
Cardiovascular Diseases
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
18+ years
Brief Summary
Aims of the study: 1. To deliver a scalable wellbeing programme to the local population of Imperial College Healthcare NHS Trust, focusing on movement. 2. To describe the natural history of long-term...
Eligibility Criteria
Inclusion
- Aged over 18 years
- Registered with the patient-facing electronic health record (Care Information Exchange)
Exclusion
- Unwilling or unable to provide informed consent
- Arm or wrist injury or condition prohibiting the safe use of a smartwatch
- Any visual impairment preventing the use of the smartwatch or smartphone application.
Key Trial Info
Start Date :
August 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06011356
Start Date
August 30 2023
End Date
August 30 2026
Last Update
October 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom (+44), United Kingdom, NW25QS